LTD Tbilisi Heart Center

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Lupus (SLE)2 trials
• Chronic kidney disease1 trial
• Dermatomyositis and polymyositis (myositis)1 trial
• Heart failure1 trial
• Type 1 diabetes1 trial
• Type 2 diabetes1 trial

Phase

• Phase 22 trials
• Phase 32 trials
• Phase 2/31 trial

Status

• Completed2 trials
• Active, not recruiting1 trial
• Enrolling by invitation1 trial
• Suspended1 trial

Lead sponsor

• Viatris Innovation GmbH2 trials
• argenx1 trial
• Corteria Pharmaceuticals1 trial
• Inversago Pharma Inc.1 trial

Running trials

• Enrolling by invitation

  Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus

  NCT06475742· Phase 3· Viatris Innovation GmbH· Source

• Active, not recruiting

  A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus

  NCT05672576· Phase 3· Viatris Innovation GmbH· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lupus (SLE)1 recruiting

Closed trials

• Completed

  Phase 2 Study of INV-202 in Patients With Diabetic Kidney Disease

  NCT05514548· Phase 2· Inversago Pharma Inc.· Source

• Completed

  A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.

  NCT05523167· Phase 2/3· argenx· Source